drugset / Trial / NCT00542750
An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents
Phase 1/2
Completed
24 enrolled
Medical University of South Carolina
American Academy of Child Adolescent Psychiatry. · collabNational Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to determine the feasibility of conducting a trial of N-Acetylcysteine in cannabis dependent adolescents.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 1200 mg | Oral |